Media Summary: Dr. Richard Vickers, chief scientific officer of R&D at Summit Therapeutics, explains how ridinilazole is unique in its spectrum of ... Stuart Johnson, MD, infectious disease clinician in the Medicine/ID department at Loyola University Medical Center, discusses the ... Hi, I'm Prerak Juthani - a PGY-3 at Stanford in Internal Medicine, and this is a video to summarize the basics of treating ...
Acurx Pharma Targets C Diff - Detailed Analysis & Overview
Dr. Richard Vickers, chief scientific officer of R&D at Summit Therapeutics, explains how ridinilazole is unique in its spectrum of ... Stuart Johnson, MD, infectious disease clinician in the Medicine/ID department at Loyola University Medical Center, discusses the ... Hi, I'm Prerak Juthani - a PGY-3 at Stanford in Internal Medicine, and this is a video to summarize the basics of treating ... Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the costs and benefits of newer ... Ken Blount, PhD, chief scientific officer at Rebiotix, details the results of the phase 2 open-label trial of RBX2660 for the prevention ...
Combining metronidazole and vancomycin was not more effective than either drug alone for treating This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
